Skip to main content
Log in

Vincristine treatment in steroid-dependent nephrotic syndrome

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Treatment of children with steroid-dependent nephrotic syndrome (SDNS) continues to be a challenge when relapses recur after treatment with cyclophosphamide and side effects or non-compliance make steroids and cyclosporin unsatisfactory. We treated 12 patients with intravenous vincristine for SDNS in a regime of 1–1.5 mg/m2 weekly for 4 weeks then monthly for 4 months. Four of the 5 patients in relapse when commencing vincristine remitted within 2 doses. Comparing relapse frequency in the 12 months before and after vincristine, there was a reduction from 4 to 1.5 (p=0.004) relapses per year. Median sustained remission was 5 months, but 1 frequently relapsing patient remains in remission 4 years after vincristine. Vincristine was also successfully used in 1 or 2 doses at weekly intervals for subsequent relapses in 5 patients. Side effects were minimal in most cases. Abdominal pain occurred in 2 patients who commenced vincristine at 1.5 mg/m2, but resolved when continued at 1 mg/m2. We felt vincristine had a role in a subset of children with challenging SDNS administered as 1 mg/m2 weekly for 4 weeks then 1.5 mg/m2 monthly for 4 months. Vincristine allowed steroid- and cyclosporin-sparing, contributed to long-term remission in some patients, and was especially valuable in children with poor compliance with oral medication. Many patients expressed a preference for a few doses of vincristine rather than a standard course of oral prednisolone or cyclosporin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Honda M (2002) Nephrotic syndrome and mizoribine in children. Pediatr Int 44:21–216

    Article  Google Scholar 

  2. Sharma RK, Sahu KM, Gulati S, Gupta A (2000) Pefloxacin in steroid dependent and resistant idopathic nephrotic syndrome. J Nephrol 13:271–274

    CAS  PubMed  Google Scholar 

  3. Chandra M, Susin M, Abitbol C (2000) Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetile. Pediatr Nephrol 14:224–226

    Article  CAS  PubMed  Google Scholar 

  4. Alsaran K, Grisaru S, Stephens D, Arbus G (2001) Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome. Clin Nephrol 56(4):289–294

    CAS  PubMed  Google Scholar 

  5. Donia AF, Amer GM, Ahmed HA, Gazareen SH, Moustafa FE, Shoeib AA, Ismail AM, Khamis S, Sobh MA (2002) Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children. Pediatr Nephrol 17:355–358

    Article  PubMed  Google Scholar 

  6. Goonsekera CDA, Koziell AB, Hulton SA, Dillon MJ (1998) Vincristine and focal segmental sclerosis: do we need a multicentre trial? Pediar Nephrol 12:284–289

    Article  Google Scholar 

  7. Almeida MP, Almeida HA, Coelho Rosa F (1994) Vincristine in steroid-resistant nephrotic syndrome. Pediar Nephrol 8:79–80

    Article  CAS  Google Scholar 

  8. Almeida M, Ribeiro M, Rosa FC (1987) Effect of vincristine in corticoresistant nephrotic syndrome. Pediatr Nephrol 1:C93 (abstract)

    Google Scholar 

  9. Schwartz GJ, Haycock GB, Edelman, CM, Spitzer A (1976). A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263

    CAS  PubMed  Google Scholar 

  10. StataCorp (2003) Stat Statistical Software: Release 8.0. Stata Corporation, College Station, TX

    Google Scholar 

  11. Vilpo JA, Koski T, Vilpo LM (2000) Selective toxicity of vincristine against chronic lymphocytic leukemia cell in vitro. Eur J Haematol 65:370–378

    Article  CAS  PubMed  Google Scholar 

  12. Kubosawa H, Kondo Y (1994) Modulation of cytoskeletal organization of podocytes during the course of aminonucleoside nephrosis in rats. Pathol Int 44(8):578–586

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joshua Yehuda Kausman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kausman, J.Y., Yin, L., Jones, C.L. et al. Vincristine treatment in steroid-dependent nephrotic syndrome. Pediatr Nephrol 20, 1416–1419 (2005). https://doi.org/10.1007/s00467-005-1940-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-005-1940-7

Keywords

Navigation